Kristen Ambrose - 13 Feb 2026 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
13 Feb 2026
Net transactions value
-$679,450
Form type
4
Filing time
18 Feb 2026, 16:17:47 UTC
Previous filing
12 Feb 2026
Next filing
19 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ambrose Kristen SVP & Chief Accounting Officer C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON /s/ Christiana Stevenson, Attorney-in-Fact 18 Feb 2026 0001856587

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $679,450 -1,393 -14% $487.76 8,734 13 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.